Ameish Govindarajan

651 total citations · 1 hit paper
34 papers, 358 citations indexed

About

Ameish Govindarajan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Ameish Govindarajan has authored 34 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 7 papers in Surgery. Recurrent topics in Ameish Govindarajan's work include Renal cell carcinoma treatment (13 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Cancer Genomics and Diagnostics (7 papers). Ameish Govindarajan is often cited by papers focused on Renal cell carcinoma treatment (13 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Cancer Genomics and Diagnostics (7 papers). Ameish Govindarajan collaborates with scholars based in United States, Brazil and Mexico. Ameish Govindarajan's co-authors include Sumanta K. Pal, Maryam Ebadi, Nazlı Dizman, Jennifer Novak, Kim Vo, Arya Amini, Jun Gong, Manuel Caitano Maia, Luís Meza and Jasnoor Malhotra and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Frontiers in Immunology.

In The Last Decade

Ameish Govindarajan

29 papers receiving 352 citations

Hit Papers

An Updated Review on Head and Neck Cancer Treatment with ... 2021 2026 2022 2024 2021 40 80 120
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. An Updated Review on Head and Neck Cancer Treatment with Radiation Therapy
    2021 148 citations Maryam Ebadi, Kim Vo et al. Cancers profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ameish Govindarajan United States 7 184 123 116 77 59 34 358
Michael Groves United States 9 80 0.4× 149 1.2× 112 1.0× 71 0.9× 60 1.0× 20 377
Francesc Xavier Avilés‐Jurado Spain 12 167 0.9× 76 0.6× 92 0.8× 144 1.9× 115 1.9× 39 405
Emma Chen Sasse Brazil 8 128 0.7× 129 1.0× 58 0.5× 52 0.7× 42 0.7× 19 294
Michael A. Samuels United States 12 141 0.8× 159 1.3× 81 0.7× 107 1.4× 93 1.6× 35 419
Alicia Lozano Spain 11 151 0.8× 160 1.3× 66 0.6× 222 2.9× 113 1.9× 44 388
Esther Uña Cidón United Kingdom 11 103 0.6× 147 1.2× 99 0.9× 15 0.2× 71 1.2× 31 320
Zhigong Wei China 10 77 0.4× 71 0.6× 36 0.3× 73 0.9× 79 1.3× 44 319
Kim Vo Japan 6 78 0.4× 52 0.4× 79 0.7× 75 1.0× 30 0.5× 14 320
Nedal Bukhari Saudi Arabia 7 91 0.5× 187 1.5× 72 0.6× 16 0.2× 72 1.2× 22 339
Stefania Martini Italy 11 113 0.6× 75 0.6× 23 0.2× 61 0.8× 90 1.5× 21 284

Countries citing papers authored by Ameish Govindarajan

Since Specialization
Citations

This map shows the geographic impact of Ameish Govindarajan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ameish Govindarajan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ameish Govindarajan more than expected).

Fields of papers citing papers by Ameish Govindarajan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ameish Govindarajan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ameish Govindarajan. The network helps show where Ameish Govindarajan may publish in the future.

Co-authorship network of co-authors of Ameish Govindarajan

This figure shows the co-authorship network connecting the top 25 collaborators of Ameish Govindarajan. A scholar is included among the top collaborators of Ameish Govindarajan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ameish Govindarajan. Ameish Govindarajan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chawla, Neal Shiv, Nicholas Salgia, Ameish Govindarajan, et al.. (2025). Comparative Genomic Characterization of Small Cell Carcinoma of the Bladder Compared With Urothelial Carcinoma and Small Cell Lung Carcinoma. JCO Precision Oncology. 9(9). e2400947–e2400947.
2.
Bergerot, Cristiane Decat, Errol J. Philip, Ameish Govindarajan, et al.. (2023). Changes in Perception of Cure Among Patients With Genitourinary Cancers Initiating Immune Checkpoint Inhibitors: A Longitudinal Study. Clinical Genitourinary Cancer. 21(6). 626–630.e3. 1 indexed citations
3.
Govindarajan, Ameish, et al.. (2023). A Case of Disseminated Histoplasmosis From California, in the Setting of Secondary Hemophagocytic Lymphohistiocytosis: A Diagnostic Challenge. Journal of Investigative Medicine High Impact Case Reports. 11. 1626003751–1626003751. 3 indexed citations
4.
Chehrazi‐Raffle, Alex, Xiaochen Li, Zeynep Büşra Zengin, et al.. (2023). Real-World Outcomes of Latinx Versus Non-Latinx Patients Treated With First-Line Immunotherapy for Metastatic Renal-Cell Carcinoma. The Oncologist. 28(12). 1079–1084. 1 indexed citations
5.
Dizman, Nazlı, Ameish Govindarajan, Zeynep Büşra Zengin, et al.. (2023). Association between time-of-day of the immune checkpoint inhibitor (ICI) infusion and disease outcomes among patients with metastatic renal cell carcinoma (mRCC).. Journal of Clinical Oncology. 41(6_suppl). 678–678. 4 indexed citations
6.
Lu, Kun‐Han, Nazlı Dizman, Regina Barragán-Carrillo, et al.. (2023). CT-based radiomics model for the prediction of genomic alterations in renal cell carcinoma (RCC). The Oncologist. 28(Supplement_1). S15–S15.
7.
Ahn, Eugene R., et al.. (2023). Integrative Oncology and the Clinical Care Network: Challenges and Opportunities. Journal of Clinical Medicine. 12(12). 3946–3946. 9 indexed citations
8.
Barragán-Carrillo, Regina, et al.. (2023). Managing Metastatic Renal Cell Carcinoma after Progression on Immunotherapy. Hematology/Oncology Clinics of North America. 37(5). 965–976. 4 indexed citations
9.
Bergerot, Cristiane Decat, Jasnoor Malhotra, Paulo Gustavo Bergerot, et al.. (2023). Improved health-related quality of life (HR-QOL) with use of an online mindfulness tool in patients with metastatic renal cell carcinoma (mRCC) receiving immunotherapy (IO).. Journal of Clinical Oncology. 41(6_suppl). 660–660. 2 indexed citations
10.
Liu, Jason, Arya Amini, Ameish Govindarajan, et al.. (2023). Targeted Therapies in Early-Stage Resectable Non–Small-Cell Lung Cancer: New Kids on the Block. JCO Precision Oncology. 7(7). e2200445–e2200445. 2 indexed citations
11.
Ebrahimi, Hedyeh, Luís Meza, Jasnoor Malhotra, et al.. (2023). Effect of CBM588 in combination with cabozantinib plus nivolumab for patients (pts) with metastatic renal cell carcinoma (mRCC): A randomized clinical trial.. Journal of Clinical Oncology. 41(17_suppl). LBA104–LBA104. 18 indexed citations
12.
Govindarajan, Ameish, Nicholas Salgia, Haiqing Li, et al.. (2023). Characterization of papillary and clear cell renal cell carcinoma through imaging mass cytometry reveals distinct immunologic profiles. Frontiers in Immunology. 14. 1182581–1182581. 6 indexed citations
13.
Liu, Jason, Ameish Govindarajan, Terence M. Williams, et al.. (2022). An Updated Review on Radiation Treatment Management in Thymus Cancers. Clinical Lung Cancer. 23(7). 561–570. 4 indexed citations
14.
Zengin, Zeynep Büşra, Jasnoor Malhotra, Cristiane Decat Bergerot, et al.. (2022). Perceptions of COVID-19 Vaccination in Patients with Genitourinary Cancers: A Survey Study. Cancer Investigation. 41(1). 70–76.
15.
Zengin, Zeynep Büşra, Ameish Govindarajan, Ramya Muddasani, et al.. (2022). Transcriptomic profiling identifies genomic markers associated with benefit from stereotactic body radiation therapy (SBRT) in oligoprogressive metastatic renal cell carcinoma (mRCC).. Journal of Clinical Oncology. 40(16_suppl). 4555–4555. 1 indexed citations
16.
Malhotra, Jasnoor, et al.. (2022). How to Treat Renal Cell Carcinoma. JACC CardioOncology. 4(2). 271–275. 8 indexed citations
17.
Zengin, Zeynep Büşra, Jasnoor Malhotra, Sabrina Salgia, et al.. (2021). 1759MO Associations between sarcopenia and gut microbiota in patients (pts) with metastatic renal cell carcinoma (mRCC) and breast cancer (BC). Annals of Oncology. 32. S1211–S1211.
18.
Salgia, Nicholas, Ameish Govindarajan, & Sumanta K. Pal. (2021). Second-line nivolumab for patients with metastatic renal cell carcinoma in India. Cancer Research Statistics and Treatment. 4(2). 401–402. 1 indexed citations
19.
Ebadi, Maryam, et al.. (2021). An Updated Review on Head and Neck Cancer Treatment with Radiation Therapy. Cancers. 13(19). 4912–4912. 148 indexed citations breakdown →
20.
Song, Ashley, Rachel Chapman, Ameish Govindarajan, et al.. (2017). Utilization patterns of extracorporeal membrane oxygenation in neonates in the United States 1997–2012. Journal of Pediatric Surgery. 52(10). 1681–1687. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Groves Breakdown of academic impact, for papers by Francesc Xavier Avilés‐Jurado Breakdown of academic impact, for papers by Emma Chen Sasse Breakdown of academic impact, for papers by Michael A. Samuels Breakdown of academic impact, for papers by Alicia Lozano Breakdown of academic impact, for papers by Esther Uña Cidón Breakdown of academic impact, for papers by Zhigong Wei Breakdown of academic impact, for papers by Kim Vo Breakdown of academic impact, for papers by Nedal Bukhari Breakdown of academic impact, for papers by Stefania Martini
Rankless by CCL
2026